Algeria vs Cape Verde: New cases tested for RR-/MDR-TB
Algeria
1.0%
in 2023
Cape Verde
4.3%
in 2024
Algeria rank
183rd
Cape Verde rank
180th
New cases tested for RR-/MDR-TB over time
- Algeria
- Cape Verde
How they compare
Cape Verde currently reports 4.3% against 1.0% in Algeria, a difference of 3.3%.
That makes Cape Verde's figure about 4.3 times Algeria's.
The two have swapped places 1 time across 8 shared years of data; in 2015 it was Algeria ahead.
Algeria ranks 183rd and Cape Verde ranks 180th of 192 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.0% | 39.2% | 36.2% | Cape Verde |
| 2020s | 1.2% | 48.7% | 47.5% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Algeria or Cape Verde?
- Cape Verde, at 4.3% against 1.0% in Algeria as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Algeria and Cape Verde?
- 3.3%, with Cape Verde ahead.
- How many years of comparable data are there for Algeria and Cape Verde?
- 8 years are reported by both, from 2015 to 2023.
- How do Algeria and Cape Verde rank globally for new cases tested for rr-/mdr-tb?
- Algeria ranks 183rd and Cape Verde ranks 180th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.